Mast Therapeutics, Inc. (MSTX)

[lux1]

why did Mast keep hidden the trial of AIR001 on cystis fibrosis?
This is P1/2 trial that will finish this month, it seems AIR001 very effective Vs Pseudomonas aeruginosa bacteria in cystic fibrosis also in combo with antibiotics.
Savara will begin soon a P3 in Cystis Fibrosis with its antibiotics AeroVanc against Pseudomonas aeruginosa .
You think this is mere happenstance?
I think that this was an old agreement, and Culley now gave AIR001 in change of something in the newco. We'll see soon how the newco is composed.

Next announcement AIR001 results for Cystis Fibrosis bacteria and then a P3 with AeroVanc combo super-drug .

https://clinicaltrials.gov/ct2/show/NCT02694393